225 related articles for article (PubMed ID: 25853628)
1. KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.
Lavrado J; Brito H; Borralho PM; Ohnmacht SA; Kim NS; Leitão C; Pisco S; Gunaratnam M; Rodrigues CM; Moreira R; Neidle S; Paulo A
Sci Rep; 2015 Apr; 5():9696. PubMed ID: 25853628
[TBL] [Abstract][Full Text] [Related]
2. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
Brito H; Martins AC; Lavrado J; Mendes E; Francisco AP; Santos SA; Ohnmacht SA; Kim NS; Rodrigues CM; Moreira R; Neidle S; Borralho PM; Paulo A
PLoS One; 2015; 10(5):e0126891. PubMed ID: 26024321
[TBL] [Abstract][Full Text] [Related]
3. Indolo[3,2-c]quinoline G-quadruplex stabilizers: a structural analysis of binding to the human telomeric G-quadruplex.
Lavrado J; Ohnmacht SA; Correia I; Leitão C; Pisco S; Gunaratnam M; Moreira R; Neidle S; Santos DJ; Paulo A
ChemMedChem; 2015 May; 10(5):836-49. PubMed ID: 25820698
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains.
Lavrado J; Borralho PM; Ohnmacht SA; Castro RE; Rodrigues CM; Moreira R; dos Santos DJ; Neidle S; Paulo A
ChemMedChem; 2013 Oct; 8(10):1648-61. PubMed ID: 23960016
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
6. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
7. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription.
Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988
[TBL] [Abstract][Full Text] [Related]
8. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
[TBL] [Abstract][Full Text] [Related]
11. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions.
Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S
Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286
[TBL] [Abstract][Full Text] [Related]
12. Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives.
Catalano R; Moraca F; Amato J; Cristofari C; Rigo R; Via LD; Rocca R; Lupia A; Maruca A; Costa G; Catalanotti B; Artese A; Pagano B; Randazzo A; Sissi C; Novellino E; Alcaro S
Eur J Med Chem; 2019 Nov; 182():111627. PubMed ID: 31446246
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
14. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Biological Evaluation of New Substituted Diquinolinyl-Pyridine Ligands as Anticancer Agents by Targeting G-Quadruplex.
Das RN; Chevret E; Desplat V; Rubio S; Mergny JL; Guillon J
Molecules; 2017 Dec; 23(1):. PubMed ID: 29301210
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.
Beauchard A; Jaunet A; Murillo L; Baldeyrou B; Lansiaux A; Chérouvrier JR; Domon L; Picot L; Bailly C; Besson T; Thiéry V
Eur J Med Chem; 2009 Oct; 44(10):3858-65. PubMed ID: 19427714
[TBL] [Abstract][Full Text] [Related]
18. RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.
Miglietta G; Cogoi S; Marinello J; Capranico G; Tikhomirov AS; Shchekotikhin A; Xodo LE
J Med Chem; 2017 Dec; 60(23):9448-9461. PubMed ID: 29140695
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
20. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]